December 22, 2008 / 7:11 AM / 11 years ago

Takeda starts Japan Phase III trials for obesity drug

TOKYO, Dec 22 (Reuters) - Takeda Pharmaceutical Co Ltd (4502.T) said on Monday it has started late stage or Phase III clinical trials for its ATL-962 obesity drug in Japan. (Reporting by Taiga Uranaka)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below